Author(s): Sun J, Zhang J, Zhao H, Shen J, Gu A, , Sun J, Zhang J, Zhao H, Shen J, Gu A,
Abstract Share this page
Abstract OBJECTIVES: To evaluate diagnostic yield and the safety of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) for mediastinal/hilar lymph nodes and intrapulmonary masses. METHODS: Between July 2009 and February 2010, 95 patients with mediastinal/hilar lymphadenopathy and/or intrathoracic peritracheal or peribronchial masses detected with computed tomography underwent EBUS-TBNA. One hundred and twelve samples were obtained from lymph nodes (LNs) and 11 samples were obtained from intrapulmonary lesions. All patients had cytological evaluation by smears and/or tissue evaluation of aspiration specimens. RESULTS: Out of the 95 patients, 60 had lung cancer, 58 of these patients were diagnosed using EBUS-TBNA without onsite cytology assistance, false negative in 2 cases. Sensitivity the of convex probe EBUS-TBNA method in distinguishing benign from malignant lymph nodes or thoracic mass was 96.67\%. In the absence of any major complications the procedure was uneventful. CONCLUSIONS: EBUS-TBNA seems a safe and effective technique in the diagnosis making bronchogenic carcinoma for mediastinal/hilar lymph nodes (LNs) and intrapulmonary masses. © Tianjin Lung Cancer Institute and Blackwell Publishing Asia Pty. Ltd.
This article was published in Thorac Cancer
and referenced in Journal of Pulmonary & Respiratory Medicine